GlassScriptPhysician profile
William Lee Evans
NPI 1467714188
$699.86
in general payments reported to CMS, 2019-2025
18 companies · $47.29 in 2025
The $47.29 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $294 · 2024: $358 · 2025: $47.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $134.16 | 2023-2025 | |
| Abbvie INC. | $119.81 | 2023-2024 | |
| Exact Sciences Corporation | $45.57 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $43.69 | 2023-2024 | Dificid |
| Amgen INC. | $43.49 | 2023-2024 | Krystexxa, Repatha, Otezla |
| Dexcom, INC. | $41.10 | 2024-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $33.55 | 2023-2024 | Jardiance, Zepbound, Mounjaro |
| Corcept Therapeutics | $33.00 | 2024 | Korlym |
| Astrazeneca Pharmaceuticals LP | $32.22 | 2024 | Flumist Quadrivalent |
| Bayer Healthcare Pharmaceuticals INC. | $30.15 | 2023 | |
| Corium, LLC | $29.04 | 2023 | Azstarys |
| Ironshore Pharmaceuticals INC. | $19.26 | 2023 | Jornay Pm |
| Acadia Pharmaceuticals INC | $18.79 | 2024 | Daybue |
| Glaxosmithkline, LLC. | $18.42 | 2023 | Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.82 | 2023 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.52 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $14.29 | 2023 | Rexulti |
| Organon LLC | $9.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.